Patent · US Active

Eluting matrix and uses thereof

US10580262B2 · kind B2 · utility

0Cited by
9References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 15, 2017
Grant dateMar 3, 2020
Priority date—
Expiry dateMay 13, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA63F2001/005
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

CXCL12 polypeptide eluting matrices encapsulating at least one cell are described for use in the treatment of autoimmune disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.